Cedars-Sinai Regenerative Medicine Institute today was awarded a $17.8 million grant from the California Institute for Regenerative Medicine to develop stem cell treatments for patients with ALS, also known as Lou Gehrig’s Disease, a progressive, fatal and currently incurable neurodegenerative disease.
The Graduate Program in Biomedical Sciences and Translational Medicine at Cedars-Sinai has been accredited by the Western Association of Schools and Colleges, an affirmation that the PhD-awarding educational effort meets the most rigorous standards of higher learning. The program’s first class of students is scheduled to earn their doctoral degrees in 2013.
Cedars-Sinai researchers have linked Kawasaki Disease, a serious childhood illness that causes inflammation of blood vessels throughout the body, with early-onset and accelerated atherosclerosis, a leading cause of heart disease in adults.
Cedars-Sinai Medical Center has 12 medical specialties nationally ranked in the 2012-2013 America’s Best Hospitals by U.S. News & World Report. Cedars-Sinai was also named as No. 2 among all hospitals in California.
Bernice Coleman, PhD, ACNP, lead heart transplant nurse practitioner in the Cedars-Sinai Heart Institute, will be among the nursing elite inducted this fall as Fellows of the American Academy of Nursing.
Neurosurgeons and researchers at Cedars-Sinai Medical Center and the Maxine Dunitz Neurosurgical Institute are adapting an ultraviolet camera to possibly bring planet-exploring technology into the operating room. If the system works when focused on brain tissue, it could give surgeons a real-time view of changes invisible to the naked eye and unapparent even with magnification of current medical imaging technologies.
Huntington's Disease Research - New “disease in a dish” model offers step forward in understanding fatal inherited disorder and ways to test therapies for it - Cedars-Sinai scientists have joined with expert colleagues around the globe in using stem cells to develop a laboratory model for Huntington’s disease, allowing researchers for the first time to test directly on human cells potential treatments for this fatal, inherited disorder.
Cedars-Sinai Medical Center has earned a distinction for the fourth year in a row as one of the best places for technology professionals to work, winning a top spot in a national ranking for its use of IT staffers as strategic partners in patient care. The medical center ranked 13th in a list of the “100 Best Places to Work in IT 2012,” its best showing to date in the report compiled by IDG’s Computerworld, a leading national publication devoted to information technology.
Brain tumor patients, families and caregivers are invited to an educational conference that will focus on patient empowerment June 23 at Cedars-Sinai Medical Center. The free, Saturday program, “Outsmarting Brain Tumors,” will feature presentations by Keith L. Black, MD, chair of the Department of Neurosurgery, and other treatment and research experts.
Cedars-Sinai Medical Center has won a civic award for a major beautification project featuring lush gardens, landscaped walkways and freshly painted buildings – a renewal meant to turn the campus into an urban oasis.
Cedars-Sinai’s Regenerative Medicine Institute has pioneered research on how motor-neuron cell-death occurs in patients with spinal muscular atrophy, offering an important clue in identifying potential medicines to treat this leading genetic cause of death in infants and toddlers.
The Barbra Streisand Women’s Heart Center in Cedars-Sinai’s Heart Institute will be named for the famed entertainer in recognition of her philanthropic commitment and it will be directed by C. Noel Bairey Merz, MD, a cardiologist and nationally respected expert on women’s cardiovascular disease.
Cedars-Sinai researchers say their examination of the fungi in the intestines suggests an important link between these microbes and inflammatory diseases such as ulcerative colitis. In the new study, published in the June 8 issue of Science, researchers at Cedars-Sinai’s Inflammatory Bowel and Immunobiology Research Institute identified and characterized the large community of fungi inhabiting the large intestine in a model of the disease.
Wengui Yu, MD, PhD, a research scientist and clinician specializing in stroke treatment and neurocritical care, has been named director of Cedars-Sinai Medical Center’s Neuroscience Critical Care Unit, one of the most advanced in the state. The recently expanded 24-bed unit, part of the Department of Neurology and Department of Neurosurgery, treats a high volume of patients with neurological disorders.
David L. Rimoin, MD, PhD, director of the Cedars-Sinai Medical Genetics Institute, a pioneer in research in skeletal disorders and abnormalities who played a pivotal role in developing mass screenings for Tay-Sachs and other heritable disorders, died early Sunday in Los Angeles. He was 75.
An overgrowth of bacteria in the gut has been definitively linked to Irritable Bowel Syndrome in the results of a new Cedars-Sinai study which used cultures from the small intestine. This is the first study to use this “gold standard” method of connecting bacteria to the cause of the disease that affects an estimated 30 million people in the United States.
Ilana Cass, MD, vice-chair of the Department of Obstetrics and Gynecology at Cedars-Sinai and a prominent specialist in gynecologic cancers, is one of only 50 physicians internationally accepted to a program that prepares exceptional women faculty for senior leadership positions at academic health centers. She is the first candidate from Cedars-Sinai to be nominated and the first accepted to the year-long Hedwig van Ameringen Executive Leadership in Academic Medicine fellowship.
Cedars-Sinai has received the Accreditation Council for Graduate Medical Education’s first approval for an obstetric anesthesiology fellowship program. The year-long fellowship provides advanced experience and training in all aspects of obstetric anesthesiology including research, administration and clinical management of both normal and high-risk patients.
Cedars-Sinai experts are available to comment on a newly-released Centers for Disease Control recommendation that Baby Boomers be screened for Hepatitis C.
Nicole Soriano had headaches before but nothing like the one that struck in the middle of one summer night. A coincidence led nine days later to Cedars-Sinai Medical Center, where a rare type of migraine was diagnosed and treated – but any moment during that time could have been disastrous.
Cedars-Sinai Heart Institute is honoring Eugene Braunwald, MD, Distinguished Hersey Professor of Medicine at Harvard Medical School, with The Eliot Corday, MD, International Prize in Heart Research. The Corday Prize has been established to recognize physicians and scientists conducting groundbreaking research that has, or very likely will, change the practice of heart medicine. Braunwald is the inaugural recipient of the annual prize.
Sandra Rome, RN, MN, AOCN, a clinical nurse specialist in hematology and oncology at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, has received the Distinguished Alumni Award from the UCLA School of Nursing.
Scientists have confirmed that mutations of a gene are responsible for some cases of a rare, inherited disease that causes progressive muscle degeneration and weakness: spinal muscular atrophy with lower extremity predominance, also known as SMA-LED.
Humberto Irigoyen’s jiu-jitsu partner had him in a choke hold when a jolt like electricity flashed through his body. “I’d never felt anything like that before,” says the former Marine . The next time the shock came – when he turned his head to breathe while swimming – it was so strong his whole body “just kind of stopped.” “That was one of my biggest scares,” recalls Irigoyen, a Los Angeles Police Department detective. . .
Cedars-Sinai Medical Center’s Stroke Program was recently spotlighted by the American Heart Association/American Stroke Association for earning the highest achievement in the association’s initiative to improve outcomes for patients suffering strokes: the Get With the Guidelines Gold Plus award.
Cedars-Sinai Medical Center has become the first West Coast site -- and one of only three nationwide -- to implant a device that stimulates the respiratory muscle in the chest and draws air into the lungs of patients suffering from amyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease) under recently approved Food and Drug Administration guidelines.
Artist Len Steckler has photographed and painted the celebrated and glamorous, the brightest stars on the planet. In one well-known series of photos, he captured images of his friend, the poet and author Carl Sandburg, with Marilyn Monroe – eight months before her death. But Steckler, who is in his early 80s, says he only began to see – really see – after the 2005 loss of his left eye to skin cancer and a series of strokes in early 2011.
Robert H. Baloh, MD, PhD, director of Cedars-Sinai Medical Center’s Neuromuscular Division, has received the ALS Association Golden West Chapter Commitment to a Cure Award.
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson’s disease, dystonia and tremor, also may help patients who suffer from obsessive-compulsive disorder or depression that fails to respond to other treatments.
If you are seeking an expert on prostate cancer Dr. Howard Sandler is available. To arrange interviews, or for more information, please contact Simi Singer at 310-423-7798.
Vice president for clinical innovation at Cedars-Sinai Medical Center available for interviews on the need for ‘living wills,’ other directives as National Healthcare Decisions Day approaches on April 16
If you’re seeking an outside expert to comment on an upcoming (embargoed) study suggesting a link between dental x-rays and brain tumors, Keith L. Black, M.D., Chairman of the Department of Neurosurgery at Cedars-Sinai Medical center is available. He hasn't had a dental x-ray in 20+ years.
In light of today's unified recommendation by nine specialty medical boards for less medical testing, Glenn D. Braunstein, MD, vice president for clinical innovation at Cedars-Sinai Medical Center is available for interviews. Dr. Braunstein says medical specialty boards are right to call for fewer tests at a time when medical providers are trying to simultaneously provide quality care and contain costs. “Our healthcare system is very fragmented, and this results in a lot of unnecessary testing,” he says.
Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute is the only cancer center in Los Angeles to receive a Commission on Cancer 2011 Outstanding Achievement Award for providing quality care and services to cancer patients.
For the second year in a row, the Cedars-Sinai Heart Institute and Comprehensive Transplant Center performed the most adult heart transplants of any U.S. medical center, according to government statistics.
Patients diagnosed with aortic stenosis who are too sick for open-heart surgery have better survival rates and an improved quality of life after undergoing catheter-based heart valve replacement than if the patients had been treated with standard medical therapy, according to a study authored by a Cedars-Sinai Heart Institute physician based on results from a multicenter clinical trial.
Cedars-Sinai researchers have determined that two prevalent drug therapies – rifaximin and lubiprostone – offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans. The findings, based on an analysis of more than two dozen large-scale clinical trials, are contained in a peer-reviewed study published online by The American Journal of Medicine and set to appear in the publication’s April print edition.
Two physicians from the Cedars-Sinai Heart Institute will receive the American College of Cardiology’s highest honors for scientific research and clinical care during the organization’s upcoming annual scientific meeting in Chicago.
Deep brain stimulation, increasingly recognized as an effective therapy for certain cases of Parkinson’s disease, dystonia and tremor, also may help patients who suffer from treatment-resistant obsessive-compulsive disorder or depression. The conference covers the principles of DBS and provides hands-on training.
Cedars-Sinai researchers have unlocked the mystery of how an inflammatory molecule is produced in the body, a discovery they say could lead to advances in the treatment of rheumatoid arthritis, Type 2 diabetes and numerous other chronic diseases that affect tens of millions of people.
Los Angeles Mayor Antonio Villaraigosa, presenting Keith L. Black, MD, with one of the city’s highest honors – the Hope of Los Angeles award – said the neurosurgeon’s innovative care and research efforts bring hope to patients throughout the region and the world.
During her 34-year career, Rita Shane, PharmD, has earned a reputation as a tireless advocate for patient safety – one who has transformed the way pharmacists perform their jobs. Now that work has brought Shane, director of pharmacy services at Cedars-Sinai Medical Center, the highest honor for health system pharmacists.
A Cedars-Sinai research scientist has been awarded two national grants totaling more than $2.5 million, including a prestigious Research Project Grant from the National Institutes of Health to study potential treatments for Alzheimer’s disease.
Every year, 7,000 babies are born at Cedars-Sinai Medical Center – many of them to Jewish parents who have questions about the role of Judaism in their new families. Now Cedars-Sinai is providing answers in a novel workshop for expectant couples seeking to navigate Judaism’s ancient traditions in their modern lives.
At the International Stroke Conference, Cedars-Sinai neurology researchers present findings on therapeutic cooling for stroke, damaging effects of normally beneficial blood component following ischemic stroke, and more.
Hundreds of health care professionals at the Cedars-Sinai Heart Institute will wear red on Friday, Feb. 3, to mark National Go Red for Women Day. The group will meet at 9 a.m. for a group photo to demonstrate support for increased research on heart disease, the No. 1 killer in the U.S. For the first time the annual gathering this year will include blood pressure checks and heart disease risk assessments.
Asma M. Moheet, MD, has been named director of Cedars-Sinai Medical Center’s Neurocritical Care Fellowship program, a two-year training program for doctors who have completed a neurology residency and wish to specialize in neurological intensive care. Moheet is one of three neurointensivists who oversee patient care in Cedars-Sinai’s highly sophisticated, 12-bed neuro ICU, which treats a high volume of patients suffering from a range of neurological and neurosurgical diagnoses.
Cedars-Sinai Medical Center’s annual Brainworks program introduces young people to the excitement and benefits of careers in science and medicine. This year’s event, occurring on Feb. 13 during Black History Month, will entertain and educate students from predominantly minority communities who attend Johnnie L. Cochran Jr. Middle School, James A. Forshay Learning Center, Lighthouse Church School, Greater New Jerusalem Missionary Baptist Church and an independent after-school program.
Robert H. Baloh, MD, PhD, an expert in genetic defects and molecular mechanisms causing neuromuscular and neurodegenerative diseases, has joined Cedars-Sinai Medical Center to advance the study of amyotrophic lateral sclerosis (ALS, Lou Gehrig’s disease), muscular dystrophies, spinal muscular atrophies and other poorly understood disorders that start in nerve cells and electrical signaling.
Drinking red wine in moderation may reduce one of the risk factors for breast cancer, providing a natural weapon to combat a major cause of death among U.S. women, new research from Cedars-Sinai Medical Center shows.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right